MedPath

The contribution of gut microbiome to liver carcinogenesis after SVR

Not Applicable
Conditions
HCV infection
Registration Number
JPRN-UMIN000026154
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with some diffuse lesions in large colon. 2. Patients with severe general complications 3. Patients who were judged to be inappropriate for this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To analysis the gut microbiome in the patients with or without liver carcinogenesis after SVR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath